SCHEMBL4937140

SCHEMBL4937140

COC(=O)c1ccc(-c2ccccc2N)o1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 2/20 0.60
ALDH1A1 P00352 6/20 0.50
HSD17B10 Q99714 3/20 0.50
CFTR P13569 1/20 0.50
KDM4E B2RXH2 4/20 0.49
HPGD P15428 3/20 0.49
TDP1 Q9NUW8 1/20 0.49
HTT P42858 3/20 0.47
KMT2A Q03164 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
POLB P06746 2/20 0.47
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SETD7 Q8WTS6 1/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3360388 0.86 SLC9A1 (0.46) SLC9A1ALDH1A1HSD17B10CFTRKDM4E
SCHEMBL3361482 0.85 SLC9A1 (0.45) SLC9A1ALDH1A1HSD17B10CFTRKDM4E
SCHEMBL30501678 0.85 SMN1; SMN2 (0.66) SLC9A1ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL23091228 0.85 SLC9A1 (0.55) SLC9A1ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL30501694 0.85 SLC9A1 (0.55) SLC9A1ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL23091170 0.85 SMN1; SMN2 (0.66) SLC9A1ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL4946365 0.82 ALDH1A1 (0.61) SLC9A1ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL7064007 0.81 SLC9A1 (0.65) SLC9A1ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL4946572 0.81 RAB9A (0.67) SLC9A1ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL4937754 0.81 ALDH1A1 (0.74) SLC9A1ALDH1A1HSD17B10KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US disclosed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US disclosed
EP-1697335-A1 FURANCARBONYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-09-06 EP disclosed
WO-2005063727-A1 FURANCARBONYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-07-14 WO disclosed
US-4773927-A ORTHO-FURANYL-,-THIENYL- OR -PYRROLYL-BENZENE SULFONYLUREAS E. I DU PONT DE NEMOURS AND COMPANY (US) 1988-09-27 US disclosed
US-4699648-A HERBICIDE, PLANT GROWTH REGULATOR E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-10-13 US disclosed
EP-0085476-B1 HERBICIDAL SULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-04-22 EP disclosed
US-4592775-A Containing hetero ring substitution E. I. DU PONT DE NEMOURS AND COMPANY (US) 1986-06-03 US disclosed
US-4460401-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1984-07-17 US disclosed
EP-0085476-A2 Herbicidal sulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-08-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them SLC9A1, NHERF1, SLC5A1 SLC9A1 1/4885ALDH1A1 297/4885HSD17B10 1301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.